Centronuclear Myopathies Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Early Phase Human Drug Trial to Investigate Dynamin 101 (DYN101) in Patients ≥ 16 Years With Centronuclear Myopathies
Condition: Centronuclear Myopathy Intervention: Drug: DYN101 Sponsor: Dynacure SAS Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 25, 2019 Category: Research Source Type: clinical trials
Prospective Natural History Study of Patients With Myotubular Myopathy and Other CentroNuclear Myopathies
Condition: Centronuclear Myopathy Intervention: Other: Standardized strength, respiratory and motor function assessments Sponsors: Institut de Myologie, France; Dynacure Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2017 Category: Research Source Type: clinical trials